Naltrexone
Low-Dose Naltrexone (LDN) is a compounded, low-dose version of the FDA-approved medication naltrexone, used off-label to support immune regulation, reduce inflammation, and help manage chronic pain conditions. LDN is widely used in functional and integrative medicine to support patients with autoimmune disorders, fibromyalgia, long COVID, chronic fatigue, and inflammatory conditions.
At standard doses (50mg), naltrexone is approved for treating opioid and alcohol dependence. At much lower doses (typically 0.5 mg to 4.5 mg), LDN works differently—modulating immune function and reducing inflammation via temporary endorphin receptor blockade.
This brief receptor interruption prompts a rebound effect, increasing the body’s natural production of endorphins and opioid growth factors, which may help balance immune activity, reduce pain, and improve overall wellness.
LDN is not habit-forming, does not cause euphoria or sedation, and is generally well tolerated when titrated appropriately.
Please note: Benefits may vary, and evidence for many use cases is still emerging. LDN is not FDA-approved for these indications.
LDN is a compounded medication and is custom-formulated by a licensed compounding pharmacy based on your needs.